ALB and acute kidney injury: Renal replacement therapy should be considered in patients who do not respond to vasoconstrictors and albumin, and in those developing severe complications of AKI (e.g. severe metabolic acidosis, severe hyperkalaemia, pulmonary oedema, uremic complications), though its effect on survival is unclear.